Sector 10 (OTCMKTS:SECI – Get Free Report) and Hologic (NASDAQ:HOLX – Get Free Report) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, valuation, dividends, profitability, analyst recommendations, institutional ownership and risk.
Earnings & Valuation
This table compares Sector 10 and Hologic’s gross revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Hologic||$4.03 billion||4.37||$456.00 million||$1.83||39.27|
Hologic has higher revenue and earnings than Sector 10. Sector 10 is trading at a lower price-to-earnings ratio than Hologic, indicating that it is currently the more affordable of the two stocks.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Hologic has a consensus target price of $86.58, suggesting a potential upside of 20.47%. Given Hologic’s higher possible upside, analysts plainly believe Hologic is more favorable than Sector 10.
This table compares Sector 10 and Hologic’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Institutional & Insider Ownership
92.6% of Hologic shares are held by institutional investors. 9.2% of Sector 10 shares are held by insiders. Comparatively, 1.7% of Hologic shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Hologic beats Sector 10 on 9 of the 10 factors compared between the two stocks.
About Sector 10
Sector 10, Inc., a development stage company, markets MRU SRU product lines and various solutions related to mobile assets. Sector 10, Inc. was incorporated in 1992 and is based in Bellevue, Washington.
Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalovirus; Aptima BV and Aptima CV/TV assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. It also offers solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology, and treatment, such as 2D and 3D digital mammography systems, image analytics software, reading workstations, ultrasound imaging, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, specimen radiology, and ultrasound and connectivity solutions, as well as breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology in the uterus; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; and the CoolSeal portfolio that includes bipolar vessel sealing devices. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.
Receive News & Ratings for Sector 10 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sector 10 and related companies with MarketBeat.com's FREE daily email newsletter.